Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Bruhn Suzanne Louise, Director. Insider active across 4 companies, notably Travere Therapeutics, Inc.. Aggregated, 11 disclosures have been published. Activity tracked since 14 May 2021. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Suzanne Louise Bruhn is a Board Member at Travere Therapeutics, Inc. In this role, she participates in corporate governance and strategic decision-making. Bruhn is involved in performance evaluation and overseeing the company's activities to ensure its growth.